Analyst Ratings for Flexion Therapeutics (FLXN)

FLXN Rating Summary

  |   Expand Research on FLXN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.1 / 10   Percentile Rank: 65%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/19/2021 Northland Carl Byrnes Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 9.12
(24.96)		 173.68% Details
10/19/2021 H.C. Wainwright N/A Downgrade Neutral
(Buy)		 10.00
(N/A)		 9.31
(24.96)		 168.1% Details